top of page

Pfizer Says COVID-19 Vaccine Shows '100% Efficacy' In Adolescents

Writer's picture: Aryaman Sinha Aryaman Sinha


New clinical trials showed that Pfizer's COVID-19 vaccine elicits "100% efficacy and robust antibody responses" in adolescents from 12 to 15 years old, the drug company announced Wednesday. The trial included 2,260 participants; the results are even better than earlier responses from participants ages 16 to 25. Nice!



Photo Credit: Franck

21 views0 comments

コメント


Thanks for submitting!

Stay updated on the latest good newz!

GoodNewzUniversal brings the top positive news about the world, daily. No matter what happens, there is always going to be good news all over the world. This website has assembled it, just for you.

    © 2023 BY ARYAMAN SINHA

    bottom of page